IRON
Disc Medicine Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.55B
P/E Ratio
—
EPS
$-6.10
Beta
2.54
52W High
$99.50
52W Low
$33.67
50-Day MA
$67.10
200-Day MA
$70.34
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Disc Medicine Inc.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-234.89M |
| Operating Margin | 0.00% |
| Return on Equity | -35.90% |
| Return on Assets | -22.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $19.52 |
| Price-to-Book | 3.36 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -7.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $38.16M |
| Float | $32.89M |
| % Insiders | 7.97% |
| % Institutions | 104.50% |
Analyst Ratings
Consensus ($100.17 target)
1
Strong Buy11
BuyData last updated: 4/8/2026